Embedded Files
About
About
MacroGel was set up as a focused outlet for the promotion and sales of macroporous hydrogels developed at Spheritech Ltd. These novel, innovative porous matrices have a broad a range of applications including solid phase peptide synthesis, solid phase oligonucleotide synthesis, enzyme immobilisation, antibody immobilisation, oral peptide drug delivery, subcutaneous drug delivery, 3D cell culture, immobilised metal affinity chromatography (IMAP), metal extraction and disinfection to name a few.
Meet the management team
Meet the management team
Dr Donald A Wellings
Dr Donald A Wellings
Don Wellings is the founder, Managing Director and Chief Scientific Officer at Spheritech Ltd.
Don is an internationally recognised authority on peptide synthesis, polymer design, and chromatography with over 40 years’ experience of working in major blue-chip organisations having held senior scientific posts in ICI, Zeneca, Avecia, and Polymer Laboratories. Prior to founding Spheritech he founded Chromatide where he worked as Chief Scientific Officer for 3 years and was credited as the sole inventor of all of the company’s intellectual property.
With a track record of innovation, he is the main inventor on over 20 patents and the sole inventor on all patents filed by SpheriTech to date.
Mr Joshua Greenwood
Mr Joshua Greenwood
Josh Greenwood is the lead research scientist at Spheritech and is a key driver in R&D, process scale-up and manufacture of the innovative porous hydrogels available from MacroGel.
Josh initiated his career 7 years ago at Spheritech Ltd. He is now an experienced peptide chemist with a specific focus on aqueous peptide synthesis by solid phase and liquid phase approaches.
Page updated
Google Sites
Report abuse